# Pioglitazone as an Adjunct for Moderate to Severe Depressive Disorder

> **NCT01109030** · PHASE2,PHASE3 · COMPLETED · sponsor: **Tehran University of Medical Sciences** · enrollment: 50 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Pioglitazone+Citalopram+Chlordiazepoxide
- **DRUG:** Placebo+ Citalopram+ Chlordiazepoxide

## Key facts

- **NCT ID:** NCT01109030
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2012-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01109030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01109030, "Pioglitazone as an Adjunct for Moderate to Severe Depressive Disorder". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01109030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*